TABLE 2.
Common hidradenitis suppurativa comorbidities
| Comorbidity | Recommendations for screening | Referrals |
|---|---|---|
| Metabolic syndrome20 | Evaluate blood pressure (>130/85 mm Hg) and lipid panel (fasting TG>150 mg/dL, HDL cholesterol<50 mg/dL)21 | Primary care |
| Diabetes mellitus20 | Order glucose laboratory testing (fasting plasma glucose≥126 mg/dL) or HbA1c (≥6.5)22 | Endocrinology |
| Polycystic ovarian syndrome23 | Screen for hirsutism, acne, irregular menses; transvaginal ultrasound | Endocrinology |
| Inflammatory bowel syndrome24 | Screen for diarrhea, bloody stool, abdominal pain | Gastroenterology |
| Inflammatory joint disease25 | Inquire about morning stiffness and joint pain or swelling | Rheumatology |
| Substance use disorder26 | Elicit patient history; urine toxicology screen for opioid or cannabis | Psychiatry and psychology |
| Depression27 | Screen with PHQ-228,a | Psychiatry and psychology |
HbA1c, hemoglobin A1c; HDL, high-density lipoprotein; PHQ-2, Patient Health Questionnaire-2; TG, triglyceride.
a
PHQ-2 is a first-step screen for depression with 2 questions: “Over the last 2 weeks, how often have you been bothered by the following problems? (1) Little interest or pleasure in doing things. (2) Feeling down, depressed, or hopeless.”
Collier. Hidradenitis suppurativa and women’s health. Am J Obstet Gynecol 2021.